Clinical trials
Completed Ascites trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 10 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 5 |
| Otsuka Pharmaceutical Co., Ltd. | 4 |
| University of Michigan | 4 |
| NovaShunt AG | 3 |
| Otsuka Beijing Research Institute | 3 |
| Sequana Medical N.V. | 3 |
| Istanbul Training and Research Hospital | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascites | 89 |
| Fibrosis | 35 |
| Liver Cirrhosis | 21 |
| Hepatic Encephalopathy | 7 |
| Hypertension, Portal | 5 |
| Liver Diseases | 5 |
| Hepatorenal Syndrome | 4 |
| Ovarian Neoplasms | 4 |
| Pleural Effusion | 4 |
| Carcinoma | 3 |
Trials
Showing 76 to 89 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.